- Corporate Officers - A
- Ackerman Joel
Insider Trading History of Ackerman Joel
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ackerman Joel since 2012.
This trader's CIK number is 1220630.
At the time of last reporting, Ackerman Joel was the Officer of Champions Oncology, Inc.. (stock ticker symbol CSBR).
Also see all insider trading activities at Champions Oncology, Inc..
Note that in the past
ACKERMAN JOEL also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Coventry Health Care Inc (CVH) by Ackerman Joel
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | CVH | 0 | $0 | 3,291 | $144,211 | 0 | $0 |
Yearly summary of insider trading at Davita Inc. (DVA) by Ackerman Joel
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | DVA | 0 | $0 | 68,769 | $10,663,377 | 188,999 | $11,765,074 |
| 2023 | DVA | 0 | $0 | 0 | $0 | 56,306 | $3,732,524 |
| 2021 | DVA | 0 | $0 | 37,760 | $4,960,153 | 145,159 | $10,000,003 |
Yearly summary of insider trading at Champions Oncology, Inc. (CSBR) by Ackerman Joel
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | CSBR | 0 | $0 | 0 | $0 | 219,689 | $636,399 |
| 2022 | CSBR | 0 | $0 | 0 | $0 | 16,667 | $53,501 |
| 2020 | CSBR | 0 | $0 | 0 | $0 | 126,940 | $670,243 |
| 2019 | CSBR | 0 | $0 | 0 | $0 | 207,278 | $446,534 |
| 2018 | CSBR | 0 | $0 | 22,535 | $383,545 | 100,000 | $210,000 |
| 2016 | CSBR | 22,535 | $37,351 | 0 | $0 | 0 | $0 |
| 2015 | CSBR | 2,710,526 | $0 | 0 | $0 | 0 | $0 |
| 2013 | CSBR | 500,000 | $250,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Ackerman Joel:
1. Coventry Health Care Inc (CVH)
2. Davita Inc. (DVA)
3. Champions Oncology, Inc. (CSBR)
Table 1. Insider trading of Coventry Health Care Inc (CVH) by Ackerman Joel
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-12-03 | CVH | Sale | 3,291 | 43.82 | 144,211 |
Table 2. Insider trading of Davita Inc. (DVA) by Ackerman Joel
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-09-16 | DVA | Option Ex | 78,999 | 75.95 | 5,999,974 |
| 2024-08-28 | DVA | Sale | 4,740 | 155.02 | 734,785 |
| 2024-08-27 | DVA | Sale | 64,029 | 155.06 | 9,928,592 |
| 2024-03-06 | DVA | Option Ex | 55,000 | 52.41 | 2,882,550 |
| 2024-02-21 | DVA | Option Ex | 55,000 | 52.41 | 2,882,550 |
| 2023-05-10 | DVA | Option Ex | 56,306 | 66.29 | 3,732,524 |
| 2021-08-09 | DVA | Option Ex | 145,159 | 68.89 | 10,000,003 |
| 2021-08-05 | DVA | Sale | 37,760 | 131.36 | 4,960,153 |
Table 3. Insider trading of Champions Oncology, Inc. (CSBR) by Ackerman Joel
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-10-31 | CSBR | Option Ex | 105,137 | 3.77 | 395,840 |
| 2023-10-17 | CSBR | Option Ex | 114,552 | 2.10 | 240,559 |
| 2022-10-19 | CSBR | Option Ex | 16,667 | 3.21 | 53,501 |
| 2020-03-03 | CSBR | Option Ex | 126,940 | 5.28 | 670,243 |
| 2019-12-02 | CSBR | Option Ex | 203,111 | 2.10 | 426,533 |
| 2019-01-02 | CSBR | Option Ex | 4,167 | 4.80 | 20,001 |
| 2018-10-12 | CSBR | Option Ex | 100,000 | 2.10 | 210,000 |
| 2018-10-01 | CSBR | Sale | 22,535 | 17.02 | 383,545 |
| 2016-10-18 | CSBR | Buy | 2,000 | 1.70 | 3,390 |
| 2016-10-13 | CSBR | Buy | 6,000 | 1.68 | 10,062 |
| 2016-10-14 | CSBR | Buy | 1,300 | 1.65 | 2,150 |
| 2016-10-06 | CSBR | Buy | 3,202 | 1.61 | 5,171 |
| 2016-10-07 | CSBR | Buy | 5,000 | 1.64 | 8,200 |
| 2016-09-23 | CSBR | Buy | 33 | 1.65 | 54 |
| 2016-09-20 | CSBR | Buy | 3,000 | 1.63 | 4,896 |
| 2016-09-21 | CSBR | Buy | 2,000 | 1.71 | 3,428 |
| 2015-03-11 | CSBR | Buy | 2,710,526 | .00 | 0 |
| 2013-01-28 | CSBR | Buy | 500,000 | .50 | 250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ackerman Joel
(Officer of Champions Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.